Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2008;67:281-282; doi:10.1136/ard.2007.082859
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism.

EDITORIAL

Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease

Patricia Woo

Paediatric and Adolescent Rheumatology Department of Immunology and Molecular Pathology, University College London, London, UK

Correspondence to:
Professor Patricia Woo, University College London, Paediatric and Adolescent Rheumatology Department of Immunology and Molecular Pathology 46, Cleveland Street London, W1T 4JF UK; patricia.woo@ucl.ac.uk

Accepted 3 January 2008

The first 150 words of the full text of this article appear below.

Systemic juvenile idiopathic arthritis (sJIA) is a distinct clinical spectrum of illnesses compared to other types of chronic arthritides in children. Typically, the clinical features include the characteristic quotidian fevers, evanescent rashes, serositis, lymphadenopathy and hepatosplenomegaly in addition to persistent and destructive arthritis at the severe end of the spectrum. The children also appear to be more prone to macrophage activation syndrome/secondary histiolymphocytic haemophagocytosis (HLH). It is generally acknowledged that a similar disease occurs rarely in adults: adult onset Still disease (AOSD). However, the clinical classifications for each were developed separately and are different from each other. The Yamaguchi AOSD criteria1 are less precise in the exclusions and are able to include a wider spectrum of clinical manifestations as compared to the International League of Associations for Rheumatology (ILAR) classification of sJIA.2

The pathogenesis of sJIA is still the subject of much research and the first reports of the role . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France
T Lequerré, P Quartier, D Rosellini, F Alaoui, M De Bandt, O Mejjad, I Kone-Paut, M Michel, E Dernis, M Khellaf, N Limal, C Job-Deslandre, B Fautrel, X Le Loët, J Sibilia, and on behalf of the Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie (SOFREMIP) and the Club Rhumatismes et Inflammation (CRI)
Ann Rheum Dis 2008 67: 302-308. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Berger, C T, Recher, M, Steiner, U, Hauser, T M (2009). A patient's wish: anakinra in pregnancy. Ann Rheum Dis 68: 1794-1795 [Full Text]  
  • Beresford, M W, Baildam, E M (2009). New advances in the management of juvenile idiopathic arthritis--2: The era of biologicals. EDUCATION AND PRACTICE 94: 151-156 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs